Elsevier

Epilepsy & Behavior

Volume 17, Issue 4, April 2010, Pages 489-496
Epilepsy & Behavior

Correlations between neurophysiological, behavioral, and cognitive function in Rett syndrome

https://doi.org/10.1016/j.yebeh.2010.01.024Get rights and content

Abstract

Rett syndrome, a neurodevelopmental disorder affecting mainly females, is caused by a mutation of the MeCP2 gene. Girls with Rett syndrome manifest diverse behavioral and cognitive phenotypes, and the reasons for this variability remain unknown. In addition, girls with Rett syndrome often have epileptic seizures and abnormal EEGs, the characteristics of which differ with the patient. The aim of the study was to verify if neurophysiological and epileptological characteristics could be correlated with cognitive measures, obtained using eye tracker technology, and behavioral scores (Vineland Adaptive Behavior Scales and Rett Assessment Rating Scale) in 18 patients with Rett syndrome (mean age 13.7 years) at clinical stages III and IV. Age at epilepsy onset and seizure frequency were strictly correlated with neuropsychological outcome, as were EEG stage and distribution of paroxysmal abnormalities. Our findings demonstrate that neurophysiological features should be considered prognostic of cognitive and behavioral outcome in the clinical management of Rett syndrome.

Introduction

Rett syndrome (RS) is an X-linked dominant neurodevelopmental disorder, affecting almost exclusively females, with an incidence ranging from 1/10,000 to 1/15,000. Clinical diagnosis of the classic form relies on a battery of obligatory criteria such as normal pre-/perinatal period and normal head circumference at birth, followed by loss of acquired skills such as communication and purposeful hand use associated with onset of stereotypies. Additional characteristic features include deceleration of head growth, gait posture ataxia, breathing dysfunction, and epilepsy [1]. About 80% of females with classic RS and 25 to 75% of those with variant forms, depending on the criteria used for diagnosis and size and age of sampled population, have mutations in MeCP2 (methyl CpG binding protein2), a transcriptional repressor gene located on Xq28 [2].

Several studies have reported a relationship between some characteristics of the phenotype and the genotype, but patients with the same MeCP2 mutation can vary greatly in phenotype, so there may be other mechanisms modulating the clinical presentation [3]. With respect to neurodevelopmental and behavioral phenotypes, girls affected by RS vary, and the reason(s) for the differences is not well understood. Moreover, the clinical and electroencephalographic picture of girls with RS follows different stages correlated with age [4], [5], and electroencephalographic patterns vary not only between patients, but also between stages of the disease [6], [7].

Epilepsy is very frequent in patients with RS, occurring in about 80% of subjects; seizures are often difficult to treat, and in several patients, antiepileptic drug polytherapy is needed [8]. It is well known that refractory epileptic seizures can be associated with neuropsychological impairment involving different cognitive functions, such as memory, attention, and mental speed [9]. The aim of our study was to delineate if and how neurological and neurophysiological impairment reflects behavioral and neuropsychological functions, to identify prognostic factors that could be important in the clinical management of girls with RS.

Section snippets

Subjects

Eighteen girls with RS (mean age = 13.7 years, range = 7–21) were classified as clinical stage III (characterized by prominent hand apraxia/dyspraxia, apparently preserved ambulation ability, and some communicative ability, mainly eye contact) or stage IV (late motor deterioration, with progressive loss of ambulation ability), according to the criteria for classic RS of Hagberg et al. [10]. Their demographic, developmental, clinical, behavioral, and genetic information, collected from all available

Results

Results are presented with respect to each of the neurophysiological measures presented above.

Discussion

Cognitive performance and behavioral features in persons with RS have scarcely been investigated. Most studies on cognitive functions and behavioral features in RS are based on information supplied by the parents and professionals who take care of the patients [18], [19]. Few studies have explored cognitive performance directly in subjects with RS: in 2006, Baptista et al. [20] demonstrated that intentional gaze is a measurable parameter in girls with RS and can be used to explore their

Acknowledgments

We thank all the RTT patients and their families for their active participation in the study.

References (32)

  • D.G. Glaze et al.

    Rett’s syndrome: correlation of electroencephalographic characteristics with clinical staging

    Arch Neurol

    (1987)
  • D.G. Glaze

    Neurophysiology of Rett syndrome

    Ment Retard Dev Disabil Res Rev

    (2002)
  • A.P. Aldenkamp et al.

    Behaviour, cognition and epilepsy

    Acta Neurol Scand

    (2005)
  • B. Hagberg

    Clinical manifestations and stages of Rett syndrome

    Ment Retard Dev Disabil Res Rev

    (2002)
  • S. Sparrow et al.

    Vineland adaptive behavior scales

    (1984)
  • R.A. Fabio et al.

    Costruzione e standardizzazione dello strumento “R.A.R.S.” (Rett Assessment Rating Scale)

    Ciclo Evol Disabil

    (2005)
  • Cited by (56)

    • Longitudinal cognitive rehabilitation applied with eye-tracker for patients with Rett Syndrome

      2021, Research in Developmental Disabilities
      Citation Excerpt :

      Clinical manifestations include severe linguistic and motor impairments that are the core of phenotype symptoms. Neurological abnormalities are reflected in several behavioural and cognitive impairments such as stereotypies, loss of speech and hand skills, gait apraxia, irregular breathing with hyperventilation while awake, and frequent seizures (Amir & Zoghbi, 2000; Cuddapah et al., 2014; Fabio et al., 2018d; Kaufmann, Johnston, & Blue, 2005; Vignoli et al., 2010). With reference to treatments of cognitive deficits, despite claims that neurologically based cognitive and behaviour deficits in patients with RTT are difficult to change or improve upon, it has been shown that patients with RTT can reach higher developmental levels in the cognitive area (Castelli, Antonietti, Fabio, Lucchini, & Marchetti, 2013; Caprì, Fabio, Iannizzotto, & Nucita, 2020; Chapleau et al., 2013; Fabio, Antonietti, Castelli, & Marchetti, 2009; Fabio, Caprì, Nucita, Iannizzotto, & Mohammadhasani, 2018, 2020b; Fabio, Giannatiempo, Antonietti, & Budden, 2009; Stasolla et al., 2014, 2015), with the use of cognitive rehabilitation.

    • Unusual double mutation in MECP2 and CDKL5 genes in Rett-like syndrome: Correlation with phenotype and genes expression

      2020, Clinica Chimica Acta
      Citation Excerpt :

      The presence of severe intellectual disability, developmental delay, autism spectrum disorders and epilepsy allow us to classify our patient as RTT‐like syndrome To assess clinical severity, we used the phenotypic severity score developed using the Rett Assessment Rating Scale (R.A.R.S.) [22]. The R.A.R.S. was obtained by a standardization procedure, involving a sample of 220 RTT patients, proving that the instrument is statistically valid and reliable [22].

    View all citing articles on Scopus
    View full text